A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

March 2, 2023

Study Completion Date

April 27, 2023

Conditions
Dry Eye Disease
Interventions
DRUG

SI-614

1 drop in each eye

DRUG

Vehicle

1 drop in each eye

Trial Locations (6)

28150

CORE Inc, Vita Eye Clinic, Shelby

38119

Total Eye Care, PA, Memphis

40206

Butchertown Clinical Trials, Louisville

89052

Center for Sight, Henderson

92663

Eye Research Foundation, Newport Beach

01810

Andover Eye Associates, Inc., Andover

All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

collaborator

Statistics & Data Corporation

INDUSTRY

lead

Seikagaku Corporation

INDUSTRY